Sponsor of the Day:
Jerkmate
https://valneva.com/about-us/our-expertise-in-travel-health/
Our Expertise in Travel Health - Valneva
Apr 3, 2024 - Valneva Travel Health is dedicated to protecting travelers’ peace of mind by offering a unique range of travel vaccines and by providing educational programs,...
travel healthexpertisevalneva
https://valneva.com/research-development/chikungunya/
Chikungunya - VLA1553 - Valneva
Mar 27, 2026 - VLA1553 is a live-attenuated, single dose investigational vaccine candidate targeting the chikungunya virus, which has spread to over 110 countries.
chikungunyavalneva
https://www.linkedin.com/company/valneva
Valneva | LinkedIn
valnevalinkedin
https://www.biospace.com/drug-development/pfizer-confident-in-valneva-partnered-lyme-vaccine-despite-missed-primary-endpoint
Pfizer ‘Confident’ in Valneva-Partnered Lyme Vaccine Despite Missed Primary Endpoint - BioSpace
Mar 23, 2026 - The multivalent candidate, being developed by Pfizer and French partner Valneva under a 2020 pact, generated higher than 73% efficacy against the tick-borne...
lyme vaccinepfizervalnevapartnereddespite
https://valneva.com/
Home - Valneva
Mar 18, 2026 - We are a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs.
valneva